Hemophilia: A Review of Perioperative Management for Cardiac Surgery

Authors

Jenny Kwak, Loyola University Medical Center
Michael Mazzeffi, University of Maryland School of Medicine
Lisa N. Boggio, Rush University
Mindy L. Simpson, Rush University
Kenichi A. Tanaka, University of Maryland School of Medicine

Document Type

Journal Article

Publication Date

1-1-2020

Journal

Journal of Cardiothoracic and Vascular Anesthesia

DOI

10.1053/j.jvca.2020.09.118

Keywords

cardiac surgery; cardiopulmonary bypass; factor IX; factor VIII; hemophilia A; hemophilia B; thromboelastography; thromboelastometry

Abstract

Hemophilia is an X-linked, recessive bleeding disorder. Improvements in factor replacement therapy and overall approach to hemophilia management have increased the lifespan and quality of life for patients with hemophilia. Thus, they are presenting for cardiac surgery related to age-related atherosclerosis, vascular disorders, and degenerative valvular disease. Although challenging, cardiac surgery can be performed safely with appropriate planning, using a multidisciplinary approach. This article provides a narrative review and framework for the perioperative management of patients with hemophilia A and B undergoing cardiac surgery.

APA Citation

Kwak, J., Mazzeffi, M., Boggio, L., Simpson, M., & Tanaka, K. (2020). Hemophilia: A Review of Perioperative Management for Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia, (). http://dx.doi.org/10.1053/j.jvca.2020.09.118